Aerpio Pharmaceuticals, Apellis Pharmaceuticals leads healthcare gainers; Shineco, Seelos Therapeutics among major losers

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares
Inotiv, Inc. Launches Proposed Public Offering of Common Shares
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.